{"id":5253,"date":"2020-10-02T10:51:00","date_gmt":"2020-10-02T10:51:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/"},"modified":"2025-02-24T16:25:50","modified_gmt":"2025-02-24T15:25:50","slug":"consensusdocument-over-cgm-vergoeding-zeer-teleurstellend","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/","title":{"rendered":"Consensusdocument over CGM-vergoeding"},"content":{"rendered":"<h3 class=\"wp-block-heading\">De Nederlandse Diabetes Federatie (NDF) presenteerde afgelopen week een nieuw consensusdocument over vergoeding van continue glucosesensoren (CGM). Hoewel dit document zou moeten staan voor meer persoonsgerichte zorg, valt de inhoud tegen. Een bredere vergoeding voor CGM komt nauwelijks terug in het document.<\/h3><p>De ontwikkelingen op het gebied van type 1 diabetes (T1D) gaan hard. Steeds meer nieuwe technologie\u00ebn om de behandeling van T1D te verbeteren zijn beschikbaar. De vergoeding van deze innovaties blijft echter achter, terwijl betere hulpmiddelen zo hard nodig zijn. Breakthrough T1D vindt dat beschikbare behandelmethoden voor iedereen beschikbaar en toegankelijk moet zijn. Helaas is dat momenteel voor de CGM niet het geval.<\/p>\n<p>In december 2019 werd de vergoeding voor een Flash Glucosesensor (FGM) verruimd, maar een bredere vergoeding voor CGM blijft nog achter. Dat het nieuwe consensusdocument voor CGM meer gericht zou zijn op persoonsgerichte zorg, stemde ons, net als vele anderen, hoopvol. Maar de inhoud van het document valt tegen. De huidige criteria worden alleen zo aangepast dat jongeren die al een CGM gebruiken deze mogen houden als ze 18 jaar oud worden.<\/p>\n<p>Hoewel dit voor deze specifieke groep goed nieuws is, hebben heel veel anderen nog geen mogelijkheid hun bloedglucose beter te regelen, omdat een CGM voor hen nog niet vergoed wordt. Breakthrough T1D-jeugdambassadeur Sanne, student Geneeskunde \u00e9n ervaringsdeskundige, schreef voor Stichting \u00e9\u00e9ndiabetes over deze teleurstelling en waarom CGM juist w\u00e9l van belang is voor veel mensen met type 1 diabetes.<\/p>\n<p>Haar verhaal lees je hier.<\/p>\n<p>Breakthrough T1D blijft zich inzetten voor toegankelijke diabeteszorg en keuzevrijheid voor iedereen met type 1 diabetes. Wij vinden dat iedereen met type 1 diabetes de mogelijkheid zou moeten hebben om een CGM te gebruiken. Op die manier kunnen pati\u00ebnten in samenspraak met behandelaars zoeken naar de meest optimale behandeling.<\/p>","protected":false,"raw":""},"excerpt":{"rendered":"<p>De Nederlandse Diabetes Federatie (NDF) presenteerde afgelopen week een nieuw consensusdocument over vergoeding van continue glucosesensoren (CGM). Hoewel dit document zou moeten staan voor meer persoonsgerichte zorg, valt de inhoud tegen. Een bredere vergoeding voor CGM komt nauwelijks terug in het document. De ontwikkelingen op het gebied van type 1 diabetes (T1D) gaan hard. Steeds [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5254,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,187],"tags":[],"class_list":["post-5253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-archief","category-behandelen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Consensusdocument over CGM-vergoeding - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consensusdocument over CGM-vergoeding - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"De Nederlandse Diabetes Federatie (NDF) presenteerde afgelopen week een nieuw consensusdocument over vergoeding van continue glucosesensoren (CGM). Hoewel dit document zou moeten staan voor meer persoonsgerichte zorg, valt de inhoud tegen. Een bredere vergoeding voor CGM komt nauwelijks terug in het document. De ontwikkelingen op het gebied van type 1 diabetes (T1D) gaan hard. Steeds [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-02T10:51:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T15:25:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Consensusdocument over CGM-vergoeding\",\"datePublished\":\"2020-10-02T10:51:00+00:00\",\"dateModified\":\"2025-02-24T15:25:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/\"},\"wordCount\":295,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg\",\"articleSection\":[\"Archief\",\"Behandelen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/\",\"name\":\"Consensusdocument over CGM-vergoeding - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg\",\"datePublished\":\"2020-10-02T10:51:00+00:00\",\"dateModified\":\"2025-02-24T15:25:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg\",\"width\":1024,\"height\":683},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consensusdocument over CGM-vergoeding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consensusdocument over CGM-vergoeding - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/","og_locale":"nl_NL","og_type":"article","og_title":"Consensusdocument over CGM-vergoeding - Breakthrough T1D","og_description":"De Nederlandse Diabetes Federatie (NDF) presenteerde afgelopen week een nieuw consensusdocument over vergoeding van continue glucosesensoren (CGM). Hoewel dit document zou moeten staan voor meer persoonsgerichte zorg, valt de inhoud tegen. Een bredere vergoeding voor CGM komt nauwelijks terug in het document. De ontwikkelingen op het gebied van type 1 diabetes (T1D) gaan hard. Steeds [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/","og_site_name":"Breakthrough T1D","article_published_time":"2020-10-02T10:51:00+00:00","article_modified_time":"2025-02-24T15:25:50+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg","type":"image\/jpeg"}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Consensusdocument over CGM-vergoeding","datePublished":"2020-10-02T10:51:00+00:00","dateModified":"2025-02-24T15:25:50+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/"},"wordCount":295,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg","articleSection":["Archief","Behandelen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/","name":"Consensusdocument over CGM-vergoeding - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg","datePublished":"2020-10-02T10:51:00+00:00","dateModified":"2025-02-24T15:25:50+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#primaryimage","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/10\/Dexcom-glucosesensor-4.jpg","width":1024,"height":683},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/consensusdocument-over-cgm-vergoeding-zeer-teleurstellend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Consensusdocument over CGM-vergoeding"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5253"}],"version-history":[{"count":8,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5253\/revisions"}],"predecessor-version":[{"id":9603,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5253\/revisions\/9603"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media\/5254"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}